Back to Search
Start Over
KEYNOTE-199 cohorts 4 and 5: Pembrolizumab (pembro) plus enzalutamide (enza) for enza-resistant metastatic castration-resistant prostate cancer (mCRPC)
- Source :
- European Urology Open Science, Vol 19, Iss , Pp e885-e886 (2020)
- Publication Year :
- 2020
- Publisher :
- Elsevier, 2020.
Details
- Language :
- English
- ISSN :
- 26661683
- Volume :
- 19
- Issue :
- e885-e886
- Database :
- Directory of Open Access Journals
- Journal :
- European Urology Open Science
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.060d8cb1019a44a3ad05a35244f2f600
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/S2666-1683(20)33171-2